hrp0095p1-453 | Diabetes and Insulin | ESPE2022

Usability of CGM for hyperglycemia detection during systemic glucoriticoid treatment.

Lukka Mari , Tillmann Vallo , Peet Aleksandr

Glucocorticoids are widely used to treat autoimmune and inflammatory diseases. The side-effects of glucocorticoids are well known, but not routinely monitored in the pediatric population. Recommendations regarding the timing of blood glucose screening are lacking and understanding about the correlation between different glucocorticoid treatment regimens and glucose variability is insufficient. Our objective was to test the usability of continuous glucose monitooring (CGM) to d...

hrp0098p2-60 | Diabetes and Insulin | ESPE2024

The incidence of type 1 diabetes among estonian children in 2007-2022 in comparison with the data from 1983 to 2006 and the impact of the covid-19 pandemic.

Mattson Sonja , Peet Aleksandr , Lukka Mari , Heilman Kaire , Einberg Ülle , Liivak Natalja , Shor Riina , Kool Pille , Tillmann Vallo

Background: The annual incidence rate (IR) of childhood-onset type 1 diabetes mellitus (T1D) among Estonian children under the age of 15 between 1983 and 2006 was 12.6 per 100 000 per year, with the highest incidence rate in the age-group 10-14.9 years. During this time period the most rapid increase in incidence was seen in age-group 0-4.9 years, with a 9.3% increase annually.Objective: To calculate the incidence of T1D...